![]() Identify resources for performing surveillance cultures, rapid diagnostic testing for viral and other selected pathogens, preparation of antimicrobial susceptibility summary reports, trend analysis, and molecular typing of clustered isolates (performed either on-site or in a reference laboratory) and use these resources according to facility-specific epidemiologic needs, in consultation with clinical microbiologists. Ensure availability of human and fiscal resources to provide clinical microbiology laboratory support, including a sufficient number of medical technologists trained in microbiology, appropriate to the healthcare setting, for monitoring transmission of microorganisms, planning and conducting epidemiologic investigations, and detecting emerging pathogens. ![]() Involve infection control personnel in the selection and post-implementation evaluation of medical equipment and supplies and changes in practice that could affect the risk of HAI. Provide ventilation systems required for a sufficient number of AIIRs (as determined by a risk assessment) and Protective Environments in healthcare facilities that provide care to patients for whom such rooms are indicated, according to published recommendations. Involve infection control personnel in decisions on facility construction and design, determination of AIIR and Protective Environment capacity needs and environmental assessments. Delegate authority to infection control personnel or their designees (e.g., patient care unit charge nurses) for making infection control decisions concerning patient placement and assignment of Transmission-Based Precautions. Include prevention of healthcare-associated infections (HAI) as one determinant of bedside nurse staffing levels and composition, especially in high-risk units. ![]() Determine the specific infection control full-time equivalents (FTEs) according to the scope of the infection control program, the complexity of the healthcare facility or system, the characteristics of the patient population, the unique or urgent needs of the facility and community, and proposed staffing levels based on survey results and recommendations from professional organizations. Provide administrative support, including fiscal and human resources for maintaining infection control programs. Make preventing transmission of infectious agents a priority for the healthcare organization. Incorporate preventing transmission of infectious agents into the objectives of the organization’s patient and occupational safety programs. Healthcare organization administrators should ensure the implementation of recommendations in this section. ![]() Practices for which insufficient evidence or no consensus regarding efficacy exists. The CDC/HICPAC system for categorizing recommendations is as follows:Ĭategory IA Strongly recommended for implementation and strongly supported by well-designed experimental, clinical, or epidemiologic studies.Ĭategory IB Strongly recommended for implementation and supported by some experimental, clinical, or epidemiologic studies and a strong theoretical rationale.Ĭategory IC Required for implementation, as mandated by federal and/or state regulation or standard.Ĭategory II Suggested for implementation and supported by suggestive clinical or epidemiologic studies or a theoretical rationale. As in other CDC/HICPAC guidelines, each recommendation is categorized on the basis of existing scientific data, theoretical rationale, applicability, and when possible, economic impact. These recommendations are designed to prevent transmission of infectious agents among patients and healthcare personnel inpatients with suspected or proven SARS all settings where healthcare is delivered. ![]()
0 Comments
Leave a Reply. |